Disc Medicine (IRON) Competitors $55.60 -0.28 (-0.50%) Closing price 04:00 PM EasternExtended Trading$55.57 -0.03 (-0.05%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends IRON vs. RVMD, BBIO, LNTH, LEGN, ELAN, CYTK, NUVL, GRFS, TGTX, and AXSMShould you be buying Disc Medicine stock or one of its competitors? The main competitors of Disc Medicine include Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Lantheus (LNTH), Legend Biotech (LEGN), Elanco Animal Health (ELAN), Cytokinetics (CYTK), Nuvalent (NUVL), Grifols (GRFS), TG Therapeutics (TGTX), and Axsome Therapeutics (AXSM). These companies are all part of the "pharmaceutical products" industry. Disc Medicine vs. Revolution Medicines BridgeBio Pharma Lantheus Legend Biotech Elanco Animal Health Cytokinetics Nuvalent Grifols TG Therapeutics Axsome Therapeutics Disc Medicine (NASDAQ:IRON) and Revolution Medicines (NASDAQ:RVMD) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership. Does the MarketBeat Community prefer IRON or RVMD? Revolution Medicines received 37 more outperform votes than Disc Medicine when rated by MarketBeat users. However, 85.71% of users gave Disc Medicine an outperform vote while only 75.83% of users gave Revolution Medicines an outperform vote. CompanyUnderperformOutperformDisc MedicineOutperform Votes5485.71% Underperform Votes914.29%Revolution MedicinesOutperform Votes9175.83% Underperform Votes2924.17% Do analysts rate IRON or RVMD? Disc Medicine currently has a consensus target price of $88.90, suggesting a potential upside of 59.89%. Revolution Medicines has a consensus target price of $66.25, suggesting a potential upside of 53.82%. Given Disc Medicine's stronger consensus rating and higher possible upside, analysts clearly believe Disc Medicine is more favorable than Revolution Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.10Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.08 Which has higher valuation & earnings, IRON or RVMD? Disc Medicine has higher earnings, but lower revenue than Revolution Medicines. Disc Medicine is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDisc MedicineN/AN/A-$76.43M-$3.98-13.97Revolution Medicines$11.58M625.67-$436.37M-$3.59-12.00 Do insiders & institutionals have more ownership in IRON or RVMD? 83.7% of Disc Medicine shares are owned by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are owned by institutional investors. 4.2% of Disc Medicine shares are owned by company insiders. Comparatively, 8.0% of Revolution Medicines shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, IRON or RVMD? Disc Medicine has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Is IRON or RVMD more profitable? Disc Medicine's return on equity of -25.24% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Disc MedicineN/A -25.24% -23.96% Revolution Medicines N/A -33.67%-30.08% Does the media prefer IRON or RVMD? In the previous week, Disc Medicine had 10 more articles in the media than Revolution Medicines. MarketBeat recorded 13 mentions for Disc Medicine and 3 mentions for Revolution Medicines. Disc Medicine's average media sentiment score of 0.74 beat Revolution Medicines' score of 0.71 indicating that Disc Medicine is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Disc Medicine 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Revolution Medicines 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDisc Medicine and Revolution Medicines tied by winning 8 of the 16 factors compared between the two stocks. Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRON vs. The Competition Export to ExcelMetricDisc MedicinePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.65B$6.93B$5.62B$9.15BDividend YieldN/A2.95%5.36%3.98%P/E Ratio-13.9710.1189.6917.66Price / SalesN/A350.271,223.6681.08Price / CashN/A65.4844.3437.71Price / Book3.925.335.134.73Net Income-$76.43M$157.56M$118.85M$225.42M7 Day Performance-2.44%2.83%1.87%-0.44%1 Month Performance-9.74%2.84%7.96%3.57%1 Year Performance-14.04%8.37%26.70%19.20% Disc Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRONDisc Medicine3.1119 of 5 stars$55.60-0.5%$88.90+59.9%-14.3%$1.65BN/A-13.9730Short Interest ↑RVMDRevolution Medicines4.3754 of 5 stars$40.29+1.0%$66.25+64.4%+41.7%$6.78B$11.58M-11.22250BBIOBridgeBio Pharma4.1032 of 5 stars$33.79-0.9%$48.08+42.3%-3.6%$6.39B$9.30M-14.02400Insider TradeShort Interest ↑News CoverageHigh Trading VolumeLNTHLantheus4.5482 of 5 stars$91.47-0.1%$131.86+44.2%+71.4%$6.36B$1.50B15.22700Short Interest ↑News CoverageLEGNLegend Biotech3.0541 of 5 stars$32.66+3.9%$80.62+146.8%-35.3%$5.96B$285.14M-34.381,800Short Interest ↓Analyst RevisionELANElanco Animal Health4.2563 of 5 stars$12.03+0.1%$16.43+36.6%-19.1%$5.94B$4.42B30.069,300Analyst ForecastCYTKCytokinetics4.1245 of 5 stars$45.74-2.7%$83.64+82.9%-39.2%$5.40B$7.53M-8.50250NUVLNuvalent2.4054 of 5 stars$75.84-0.2%$112.36+48.2%+9.7%$5.39BN/A-21.8640Insider TradeNews CoveragePositive NewsGRFSGrifols2.5876 of 5 stars$7.27+0.4%N/A-13.3%$5.00B$7.01B0.0023,737TGTXTG Therapeutics3.9142 of 5 stars$29.55+1.4%$40.67+37.6%+105.4%$4.60B$233.66M-295.47290AXSMAxsome Therapeutics4.6408 of 5 stars$91.93-1.9%$130.69+42.2%+13.8%$4.45B$270.60M-14.08380Analyst ForecastShort Interest ↓News Coverage Related Companies and Tools Related Companies Revolution Medicines Alternatives BridgeBio Pharma Alternatives Lantheus Alternatives Legend Biotech Alternatives Elanco Animal Health Alternatives Cytokinetics Alternatives Nuvalent Alternatives Grifols Alternatives TG Therapeutics Alternatives Axsome Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRON) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRON Stock Alerts